Arene Ruthenium(II) Complexes as Low-Toxicity Inhibitor against the Proliferation, Migration, and Invasion of MDA-MB-231 Cells through Binding and Stabilizing c-myc G-Quadruplex DNA-Reference-Cited by-同舟云学术

Arene Ruthenium(II) Complexes as Low-Toxicity Inhibitor against the Proliferation, Migration, and Invasion of MDA-MB-231 Cells through Binding and Stabilizing c-myc G-Quadruplex DNA

Published:2016-01-19 Issue:3 Volume:35 Page:317-326
ISSN:0276-7333
Container-title:Organometallics
language:en
Short-container-title:Organometallics

Author:

Wu Qiong¹,Zheng Kangdi²,Liao Siyan³,Ding Yang²,Li Yangqiu¹,Mei Wenjie²

Affiliation:

1. Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, 510632, China

2. School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, China

3. School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 510180, China

Funder

National Natural Science Foundation of China

Department of Science and Technology, Guangdong Pharmaceutical University

First Affiliated Hospital, Guangdong Pharmaceutical University

Guangzhou Municipality

Guangdong Province

Publisher

American Chemical Society (ACS)

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.organomet.5b00820

Reference54 articles.

1. Drug transporters in breast cancer: response to anthracyclines and taxanes

2. Iodide transport and breast cancer

3. Panax notoginseng saponins (PNS) inhibits breast cancer metastasis

4. In Vitro and in Vivo Evaluation of Ruthenium(II)−Arene PTA Complexes

5. In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diruthenium complexes incorporating carboxylated chalcones with phenyl or ferrocenyl units: Synthesis, structural, electrochemical and DNA binding studies;Journal of Organometallic Chemistry;2024-04

2. Cyclometalated ruthenium complexes overcome cisplatin resistance through PI3K/mTOR/Nrf2 signaling pathway;Metallomics;2024-01

3. Recent trends in the design and delivery strategies of ruthenium complexes for breast cancer therapy;Dalton Transactions;2024

4. Investigating the anticancer potential of 4-phenylthiazole derived Ru(ii) and Os(ii) metalacycles;Dalton Transactions;2024

5. Ruthenium arene complexes with chalcone ligands incorporating pyridyl and anthryl units: Synthesis, aqueous stability and interaction with quadruplex DNA;Inorganica Chimica Acta;2023-12